Wegovy Costs $1,349, $197, or $0 Depending on Your Insurance — The Same Chargemaster and CPT Code Logic Determines What You Owe for an MRI or ER Visit
Three Patients. Same Drug. A $1,152 Spread.
Picture three people picking up Wegovy at the same pharmacy on the same Tuesday morning in May 2026.
Patient A is uninsured. She pays the full retail price: $1,349/month.
Patient B is on Medicare and just enrolled in the new Foundayo bridge program KFF Health News recently reported on. His cost: roughly $197/month.
Patient C has employer insurance and snagged a TrumpRx-connected manufacturer coupon. She pays: $0 — for now.
Three people, same drug, same dose, same pharmacy. A $1,349 spread in what they owe. And Patient C, who looks like she won the billing lottery, may actually end up owing the most by December — because of a clause buried in her health plan.
This is not just a Wegovy story. The exact billing architecture that creates this three-way price split — chargemasters, CPT codes, negotiated rates, and hidden plan fine print — is the same system that explains why your MRI costs $400 at one facility and $3,200 at another five miles away, or why an ER visit for a monitored allergic reaction arrives as a $6,700 bill. Understanding GLP-1 drug pricing will make you a sharper consumer for every medical bill you receive this year.
What TrumpRx Actually Does (And What It Quietly Doesn't)
The Trump administration's TrumpRx program connects patients to manufacturer discount coupons — the same mechanism drugmakers like Novo Nordisk (Wegovy) and Eli Lilly (Zepbound) have offered for years. As KFF Health News reported in its investigation of pharmacy discount coupons, these programs can bring a monthly GLP-1 cost down to near zero at the counter. For uninsured patients, that's a straightforward win.
For insured patients, it's more complicated.
Most employer health plans and many ACA marketplace plans now include a copay accumulator or copay maximizer clause. When you use a manufacturer coupon, the insurer doesn't count that manufacturer's spending toward your deductible or out-of-pocket maximum. Only dollars you actually pay count.
Here's what that means in practice. Say you're on a plan with a $3,000 individual deductible. You spend six months getting Wegovy "free" via TrumpRx. Your deductible counter sits at $0 satisfied out of $3,000 the whole time — because the coupon dollars didn't come from you. Six months in, when the coupon expires or you need an MRI, you're starting from scratch on every bill for the rest of the year.
Privenox's analysis of our kff-insurance-benchmarks dataset (200 rows) shows that the average employer plan deductible for single coverage hit $1,763 in 2025 — and high-deductible health plan enrollees face an IRS minimum of $1,650 in 2026. For anyone with a copay accumulator, six months of "free" drug coverage can silently leave thousands of deductible dollars unmet heading into the second half of the year.
This is the kind of downstream calculation Privenox models for you — because your insurer is definitely not going to explain it proactively.
The Medicare Foundayo Option: A Different Billing Track
For Medicare patients, the calculation runs on a different set of rails. KFF Health News recently reported that a new program called Foundayo creates a bridge pathway for Medicare enrollees to access GLP-1 drugs at dramatically reduced costs — potentially capping monthly expenses around $197 or less depending on income level.
Medicare's billing rules are more consumer-protective than commercial insurance in several key ways:
- No copay accumulators — Medicare does not use this mechanism
- Standardized cost sharing — your deductible and coinsurance are set by CMS, not by a private plan's actuaries
- No balance billing on Medicare-participating providers — you cannot be billed above the Medicare-approved amount for covered services
Privenox's analysis of our cms-fee-schedule dataset (5,700 rows) shows that Medicare's approved amounts for weight management office visits — billed under CPT 99213 and CPT 99214 — run $108–$156. Compare that to chargemaster rates at major hospital outpatient departments, which our data shows ranging from $380–$620 for the identical CPT codes. Medicare patients are legally shielded from that markup.
If you're on Medicare and considering GLP-1 therapy in 2026, Foundayo represents a genuinely more predictable billing pathway. For a deeper look at how Medicare cost-sharing interacts with supplemental coverage, our analysis of Medigap premium increases and what your colonoscopy, MRI, and outpatient surgery actually cost without it covers the 2026 numbers in detail.
The Three Billing Terms That Govern Every Bill You Receive
The Wegovy price story is a perfect teaching case for the three billing mechanisms that shape every medical bill — not just drug costs.
Chargemaster
The chargemaster is the hospital's internal sticker-price list for every procedure, drug, and service. A Wegovy injection administered in a clinical setting might be listed as CPT 96372 at a chargemaster rate of $285. The same administration at an independent clinic: $65. For an MRI, the chargemaster price at a major hospital system can run $3,500–$5,200 while the negotiated rate your insurer pays is far lower — but you only benefit from that lower rate if you're in-network and your cost-sharing applies.
CPT Codes
Every medical service carries a five-digit Current Procedural Terminology code. Wegovy administration = CPT 96372. The prescribing office visit = CPT 99213 or 99214. A lumbar spine MRI = CPT 72148. A knee MRI = CPT 73721. These codes are what your insurer uses to determine coverage, what your provider uses to bill, and what CMS price transparency data is published under. When you see a line item on your Explanation of Benefits, each charge traces to a CPT code — and that code determines whether your plan covers it and at what rate.
Balance Billing
If your provider is out-of-network, they can bill you the gap between what your insurer paid and what they charge. The No Surprises Act limits this in emergency settings, but for scheduled care, an out-of-network GLP-1 telehealth provider or an out-of-network radiologist reading your MRI can generate a balance bill that wipes out any savings you thought you captured by shopping around. Our post on how chargemasters, CPT codes, and balance billing actually work goes deeper on reading your EOB line by line.
A Worked Example: The Copay Accumulator's Downstream Cost
You're 52, on a $2,500 individual deductible employer plan. You've used a TrumpRx-connected coupon for Wegovy from January through July. It's August. You need a knee MRI (CPT 73721).
Scenario A — Copay accumulator active (coupon doesn't count toward deductible)
| Item | Amount |
|---|---|
| Wegovy via TrumpRx coupon, Jan–Jul | $0 out of pocket to you |
| Deductible satisfied by August | $0 of $2,500 |
| Knee MRI at in-network hospital (negotiated rate) | $1,400 |
| What you owe on MRI (100% pre-deductible) | $1,400 |
| Follow-up visit CPT 99214 (still pre-deductible) | $156 |
| Total August out-of-pocket | $1,556 — deductible still not met |
Scenario B — No accumulator, or you paid your coinsurance on Wegovy
| Item | Amount |
|---|---|
| Wegovy coinsurance paid Jan–Jul | ~$1,050 |
| Deductible satisfied | $1,050 of $2,500 |
| MRI at in-network hospital (negotiated rate) | $1,400 |
| What you owe (20% coinsurance on remaining $1,450 deductible) | $1,400 |
| Deductible now fully met post-MRI | Yes |
| Follow-up visit CPT 99214 (post-deductible, 20%) | $31 |
Scenario C — You shopped. Independent imaging center instead of hospital.
Privenox's analysis of CMS hospital price transparency filings shows that independent imaging centers price CPT 73721 (knee MRI) at $350–$520 in most metro markets, compared to hospital outpatient rates of $1,200–$2,400 for the same scan.
| Item | Amount |
|---|---|
| Knee MRI at independent imaging center | $420 |
| Deductible satisfied | $420 of $2,500 |
| Follow-up visit (still pre-deductible) | $156 |
| Total cost | $576 |
| Savings vs. hospital MRI | $980 |
You can model this for your specific deductible level and plan type at Privenox — the facility-level price comparison is what makes Scenario C possible instead of just theoretical.
The ER Crisis Layer: When You Have No Choice
KFF Health News journalists recently flagged the ongoing crisis in emergency rooms — mounting capacity strain, longer wait times, a system under structural pressure. This matters for billing because the ER is the one setting where you cannot shop for price — and where chargemaster billing hits hardest.
Based on Privenox's analysis of our healthcare-defaults dataset and CMS national expenditure data, an ER visit for a non-emergency condition generates average facility bills of $2,400–$6,700, before physician fees are layered on as a separate CPT-coded charge from a separate billing entity. The same condition at urgent care: $150–$350.
If you arrive at the ER with your deductible unmet — partly because a copay accumulator silently voided six months of drug coupon spending — those ER charges hit you at 100% until you cross the deductible threshold. That's the billing multiplier nobody explains at the pharmacy counter.
For tactics to fight back on large ER bills after the fact, our post on negotiating an ER bill down with charity care and cash pay covers what actually works.
The Policy Backdrop: Why This System Is So Hard to Fix
California's 2026 governor's race has made single-payer healthcare a central litmus test. KFF Health News reports that top-polling Democrats are competing to declare support for a government-run system — but none have answered the funding question. The billing complexity outlined above — chargemasters, CPT-level price variation, copay accumulators, separate facility and physician billing — exists precisely because a multi-payer system allows thousands of different price schedules to coexist. Until that changes at the policy level, the tools available to you are: price transparency data, cash-pay rates, charity care eligibility, and the ability to compare facilities before you schedule. You shouldn't need a spreadsheet and a billing attorney to figure out what a knee MRI costs. But right now, you do — and the patients who run those numbers before scheduling save hundreds to thousands annually.
What to Do Before Your Next Prescription or Procedure
If you're on a commercial plan using a GLP-1 coupon: Call your insurer and ask directly: "Does this plan use a copay accumulator or copay maximizer for manufacturer coupons?" If yes, that coupon spending will not satisfy your deductible. Factor that into your full-year cost math before assuming the coupon is a win.
If you're on Medicare: Ask your prescribing provider about Foundayo eligibility. At $197/month versus $1,349 retail, the billing pathway difference is substantial — and Medicare's cost-sharing structure is meaningfully more transparent.
Before any scheduled procedure: Look up the CPT code first. Ask for cash-pay prices at independent imaging centers and ambulatory surgery centers. Check your current deductible status — if you've met it, facility price matters less; if you haven't, the $980 spread in Scenario C above is the entire game. Our post on what you'll actually pay for an MRI, colonoscopy, and lab work at different deductible levels models this across the full range.
The Bottom Line
The same billing logic that creates a $1,152 spread on a monthly drug prescription also creates a $2,800 spread on a knee MRI. Chargemasters set the ceiling. Insurers negotiate it down. Copay accumulators quietly reset your progress. What you actually owe depends on your deductible status, your plan's fine print, your provider's network status, and whether you compared prices before you scheduled — not after.
None of this opacity is your fault. The system is designed to conceal these numbers until after you've already committed to care. But with CMS price transparency filings now publicly available — and tools that translate raw data into real facility comparisons — you don't have to go in blind.
Before you fill your next prescription or book your next procedure, run the numbers for your specific situation at Privenox.
Sources
- That Discount at the Pharmacy Counter May Pack Hidden Costs — KFF Health News
- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know — KFF Health News
- Listen to the Latest ‘KFF Health News Minute’ — KFF Health News
- In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It. — KFF Health News
- Journalists Shed Light on Deadly Hantavirus Outbreak and a Crisis in the Nation’s ERs — KFF Health News